Cargando…
Functional patient-derived cellular models for neuropsychiatric drug discovery
Mental health disorders are a leading cause of disability worldwide. Challenges such as disease heterogeneity, incomplete characterization of the targets of existing drugs and a limited understanding of functional interactions of complex genetic risk loci and environmental factors have compromised t...
Autores principales: | Lago, Santiago G., Tomasik, Jakub, Bahn, Sabine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888004/ https://www.ncbi.nlm.nih.gov/pubmed/33597511 http://dx.doi.org/10.1038/s41398-021-01243-8 |
Ejemplares similares
-
The druggable schizophrenia genome: from repurposing opportunities to unexplored drug targets
por: Lago, Santiago G., et al.
Publicado: (2022) -
Perspective: Chicken Models for Studying the Ontogenetic Origin of Neuropsychiatric Disorders
por: Huang, Xiaohong, et al.
Publicado: (2022) -
Drug discovery for psychiatric disorders using high-content single-cell screening of signaling network responses ex vivo
por: Lago, Santiago G., et al.
Publicado: (2019) -
The Role of the Patient Partnership in Designing Research on Neuropsychiatric Issues in Hypoparathyroidism
por: Rubin, Mishaela R
Publicado: (2023) -
Paramagnetic NMR in drug discovery
por: Softley, Charlotte A., et al.
Publicado: (2020)